Sesen Bio, Inc.
SESN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $26,276 | $26,123 | $26,068 |
| - Cash | $2,777 | $1,999 | $7,740 | $17,909 |
| + Debt | $609 | $1,700 | $2,325 | $2,481 |
| Enterprise Value | – | $25,977 | $20,708 | $10,640 |
| Revenue | $0 | $0 | $0 | -$10,630 |
| % Growth | – | – | 100% | – |
| Gross Profit | $0 | $0 | $0 | -$10,630 |
| % Margin | – | – | – | 100% |
| EBITDA | $44,717 | $0 | $0 | $4,213 |
| % Margin | – | – | – | -39.6% |
| Net Income | $44,717 | -$9,774 | -$9,266 | $5,444 |
| % Margin | – | – | – | -51.2% |
| EPS Diluted | 1.07 | -0.23 | -0.22 | 1.49 |
| % Growth | 565.2% | -4.5% | -114.8% | – |
| Operating Cash Flow | $1,908 | -$5,904 | -$10,067 | -$60,719 |
| Capital Expenditures | $0 | $0 | $0 | $12 |
| Free Cash Flow | $1,908 | -$5,904 | -$10,067 | -$60,707 |